Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Dr Reddys Laboratories (RDY) over the last 13 years, with Q3 2025 value amounting to $3.9 billion.

  • Dr Reddys Laboratories' Retained Earnings rose 1367.52% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year increase of 1367.52%. This contributed to the annual value of $3.7 billion for FY2025, which is 1614.83% up from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Retained Earnings stood at $3.9 billion, which was up 1367.52% from $3.6 billion recorded in Q1 2025.
  • In the past 5 years, Dr Reddys Laboratories' Retained Earnings ranged from a high of $3.9 billion in Q3 2025 and a low of $2.1 billion during Q1 2021
  • Its 5-year average for Retained Earnings is $2.9 billion, with a median of $2.8 billion in 2023.
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 746.83% in 2021, then surged by 2178.89% in 2024.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Retained Earnings stood at $2.3 billion in 2021, then grew by 7.53% to $2.4 billion in 2022, then increased by 18.33% to $2.9 billion in 2023, then grew by 18.15% to $3.4 billion in 2024, then increased by 13.68% to $3.9 billion in 2025.
  • Its Retained Earnings was $3.9 billion in Q3 2025, compared to $3.6 billion in Q1 2025 and $3.4 billion in Q3 2024.